CDK2 and embryonal carcinoma: In addition, in the embryonal carcinoma cell line NTERA-2, cyclin E-dependent CDK2 activity, but not cyclin D3-dependent CDK4 activity, was suppressed as a result of hexamethylene-bisacetamide-induced differentiation (Baldassarre et al, 1999).